ArticleCancer management and research2020

MiR-29b-3p Reverses Cisplatin Resistance by Targeting COL1A1 in Non-Small-Cell Lung Cancer A549/DDP Cells.

Rui Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.